Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men

• Main Authors: Alex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, Cheng Shiun Leu, Iván C. Balán, William Brown, Christine Rael, Barbra A. Richardson, Jeanna M. Piper, Linda Gail Bekker, Suwat Chariyalertsak, Anupong Chitwarakorn, Pedro Gonzales, Timothy H. Holtz, Albert Liu, Kenneth H. Mayer, Carmen D. Zorrilla, Javier R. Lama, Ian McGowan, Ross D. Cranston
• 格式: 雜誌
• 出版: 2018
• 主題: Agricultural and Biological Sciences; Arts and Humanities
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033365678&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/43464
• 機構: Chiang Mai University

© 2017, Springer Science+Business Media, LLC, part of Springer Nature. Oral pre-exposure prophylaxis (PrEP) can prevent HIV transmission. Yet, some may prefer not to take systemic daily medication. MTN-017 was a 3-period, phase 2 safety and acceptability study of microbicide gel applied rectally eit...